Skip to content

Author

A. Mostaghimi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial.

BACKGROUND The autoimmune disorder alopecia areata (AA) results in patchy or complete hair loss. OBJECTIVE To evaluate the efficacy and safety of the Janus kinase 1/2 inhibitor deuruxolitinib dosed 8 mg twice daily (BID) or 16 mg once daily (QD) in adults with severe AA. METHODS In this phase 2 study (NCT03811912),...

Brett King, Steven Kempers, N. Mesinkovska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.